I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact ...

After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery ...

Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her ...

Dr. Andrew M. Evens discussed the importance of differentiating AYA cancers from other age groups, specifically focusing on ...

Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives.

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.

The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate ...

Proton therapy may reduce urinary, bowel and sexual side effects in prostate cancer by minimizing radiation exposure to ...

DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...